Last reviewed · How we verify
NCT07001176: CAF+RE+Oxy
Caffeine, Resistance Exercise and Muscle/Cerebral Oxygenation
NA trial testing Caffeine in Caffeine and Resistance Exercise in 12 participants. Completed in 23 December 2024.
23 December 2024
Quick facts
| Lead sponsor | University of Alcala |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | other |
| Enrollment | 12 |
| Start date | 1 January 2024 |
| Primary completion | 23 December 2024 |
| Estimated completion | 23 December 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Caffeine (caffeine) — full drug profile →
- Placebo
Conditions studied
- Caffeine and Resistance Exercise — all drugs for Caffeine and Resistance Exercise →
Sponsor
University of Alcala
Who can join
Adults 18 to 35, male only, with Caffeine and Resistance Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Several studies have evaluated and confirmed the ergogenic effects of acute caffeine intake on sports performance. However, the mechanism responsible for this ergogenic effect remains to be elucidated. Objectives: This study aims to evaluate the acute effects of caffeine intake on muscle and cerebral oxygen during muscular strength, power, muscle endurance performance. and muscle electrical activity in young adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07001176
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Caffeine
Trials testing the same drug.
- NCT07456670 — Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support · Phase 2 · not yet recruiting
- NCT07520864 — Effects of Caffeine on Elite Weightlifting Performance · NA · completed
- NCT07479875 — Caffeine Supplementation and Strength Endurance in Brazilian Jiu-jitsu Athletes · NA · completed
- NCT07466732 — Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males · EARLY_PHASE1 · enrolling by invitation
- NCT07458594 — Combined Caffeine and Rhodiola Rosea on Aerial Duel Performance in Soccer · NA · completed
Other recruiting trials for Caffeine and Resistance Exercise
Currently open trials in the same condition.
- NCT06610110 — Caffeine, CYPA12 and Resistance Exercise · NA · recruiting
Other University of Alcala trials
Trials by the same sponsor.
- NCT06599164 — Evaluation of Vastus Medialis Muscle Inhibition in Indoor Soccer Players With and Without ACL Injury · not yet recruiting
- NCT06587412 — Treatment of Lateral Epicondylalgia With Shock Waves · NA · recruiting
- NCT07333443 — Caffeine and Sport Climbing Performance · NA · completed
- NCT07015008 — Sleep and Maximal Fat Oxidation · NA · completed
- NCT06723821 — Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07001176 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alcala
- Last refreshed: 3 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07001176.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing